Glaxosmithkline Pharmaceuticals fundamental analysis
GLAXO
2529
25.20 (-0.99%)Last updated on 19 Dec, 2025 | 15:31 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Glaxosmithkline Pharmaceuticals Fundamentals
P/E Ratio
44.95
P/B Ratio
25.14
Div. Yield
2.13
Sector P/E
70.53
Sector P/B
0.97
Sec. Div. Yield
0.56
Glaxosmithkline Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 44.95, compared to the sector average of 70.53. Its P/B Ratio stands at 25.14, while the sector’s is 0.97. In terms of returns, the stock offers a Dividend Yield of 2.13%, which is than the sector’s 0.56%.
Glaxosmithkline Pharmaceuticals Score Card
Price
Attractive
Growth
Poor
Quality
Good
Management
Good
On its scorecard, Glaxosmithkline Pharmaceuticals reflects: Price – Attractive, Growth – Poor, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
